An appropriate transitional period is necessary to allow Member States to prepare for the mandatory use of Eudamed and to take account of the changes introduced by Directive 2007/47/EC of the European Parliament and of the Council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market [OJ L 247, 21.9.2007, p. 21.].
Recital 8, Decision_act (EU) 2010/227
In force
- celex=31990L0385
- celex=31993L0042
- celex=31998L0008
- celex=32007L0047
- num:eu=1990/385
- num:eu=1993/42
- num:eu=2007/47